Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
21/05/2025 13:51
May 21 (Reuters) - SK Bioscience Co Ltd 302440.KS: SK BIOSCIENCE CO LTD - WINS PATENT LAWSUIT AGAINST PFIZER OVER PNEUMOCOCCAL VACCINE SK BIOSCIENCE CO- FROM 2027, WILL BE ABLE TO MANUFACTURE AND SELL SKYPNEUMO DOMESTICALLY Source text: ID:nPnng2h8a Further company coverage: 302440.KS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine